The Problem With Moderna

LMT is trading down because people feel that Congress isn't going to spend as much on defense. Novo Nordisk has been very highly recommended, but then when you get competition from the Lilly with the obesity drug, Novo Nordisks is getting spanked. I am a believer in low-durnup. Olga, I want you to stick with it.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app